Cannabis-Based Therapies Improve Alzheimer’s-Related Agitation
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Navigating the Complexities of Medical Cannabis Use Among Older Adults
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Curaleaf International launches CPD-accredited medical cannabis education platform
Curaleaf International has launched a CPD-accredited medical cannabis education platform to support clinicians. This platform provides structured learning pathways to improve cannabis clinical knowledge. It addresses the critical need for accredited…
CBD Reduces Blood Pressure in a Dose-Dependent Manner
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Endothelial cannabinoid CB1 receptor deficiency reduces shear stress-induced arterial disease
Endothelial CB1 receptor deficiency reduces shear stress-induced arterial disease by limiting arterial stiffening and plaque formation. This mechanism highlights the role of CB1 activation in vascular disease progression. Understanding this helps…
DEA’s Own Pharmacologist Undercuts Marijuana Rescheduling Order
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Dateline Rice for July 8, 2026
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
Cannabis Health Announces Two-City Symposium Series Across Frankfurt and London This Autumn
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
EU Medical Cannabis Faces Its Most Consequential Regulatory Overhaul
/* Suppress TOC widgets */ #ez-toc-container, .ez-toc-wrap, .ez-toc-v2_0, div.ez-toc-v2_0, div#ez-toc-container { display: none !important; visibility: hidden !important; height: 0 !important; opacity: 0 !important; } /* Constrain oversized headline…
UK Medical Cannabis Registry: A Clinical Outcomes Analysis for Autism Spectrum Disorder
This UK medical cannabis registry autism analysis provides real-world data on efficacy and safety for autism spectrum disorder patients. It highlights symptom improvements and patient responses to cannabinoid therapy. Clinicians gain valuable insights…
